865
Views
10
CrossRef citations to date
0
Altmetric
Clinical Study

The Effects of Proteinuria on Urinary Cystatin-C and Glomerular Filtration Rate Calculated by Serum Cystatin-C

, , , , &
Pages 676-684 | Received 28 Nov 2011, Accepted 28 Feb 2012, Published online: 18 May 2012

REFERENCES

  • Chang YS. Methods for glomerular filtration rate measurement. Korean J Nephrol. 2006;25(4):521–524.
  • Macisaac RJ, Tsalamandris C, Thomas MC, . Estimating glomerular filtration rate in diabetes: A comparison of cystatin-C- and creatinine-based methods. Diabetologia. 2006;49(7): 1686–1689.
  • Han KH, Han SY, Kang YS, Cha DR. Serum cystatin C concentration compared with serum creatinine concentration as a marker of glomerular filtration rate. Korean J Nephrol. 2006;25:737–744.
  • Shlipak MG, Praught ML, Sarnak MJ. Update on cystatin C: New insights into the importance of mild kidney dysfunction. Curr Opin Nephrol Hypertens. 2006;15(3):270–275.
  • Zahran A, El-Husseini A, Shoker A. Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review. Am J Nephrol. 2007;27(2):197–205.
  • Beauvieux MC, Le Moigne F, Lasseur C, . New predictive equations improve monitoring of kidney function in patients with diabetes. Diabetes Care. 2007;30(8):1988–1994.
  • Donahue RP, Stranges S, Rejman K, Rafalson LB, Dmochowski J, Trevisan M. Elevated cystatin C concentration and progression to pre-diabetes: The Western New York study. Diabetes Care. 2007;30(7):1724–1729.
  • de Boer IH, Steffes MW. Glomerular filtration rate and albuminuria: Twin manifestations of nephropathy in diabetes. J Am Soc Nephrol. 2007;18(4):1036–1037.
  • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6):461–470.
  • Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18(10):2024–2031.
  • Sung SA, Kim JY, Jo SK, Cho WY, Kim HK. Serum cystatin C compared with other markers for glomerular filtration rate. Korean J Nephrol. 2006;25:551–559.
  • Kim Y, Min WK, Rhew J. Assessment of the accuracy and precision of cystatin C-based GFR estimates and Cr-based GFR estimates in comparison with Cr51-EDTA GFR. Korean J Lab Med. 2007;27:34–39.
  • Perkins BA, Ficociello LH, Ostrander BE, . Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol. 2007;18(4): 1353–1361.
  • Martin MV, Barroso S, Herraez O, de Sande F, Caravaca F. Cystatin C as estimator of glomerular filtration rate in patients with advanced chronic renal disease. Nefrologia. 2006;26(4):433–438.
  • Pucci L, Triscornia S, Lucchesi D, . Cystatin C and estimates of renal function: Searching for a better measure of kidney function in diabetic patients. Clin Chem. 2007;53(3):480–488.
  • Macdonald J, Marcora S, Jibani M, . GFR estimation using cystatin C is not independent of body composition. Am J Kidney Dis. 2006;48(5):712–719.
  • Uchida K, Gotoh A. Measurement of cystatin-C and creatinine in urine. Clin Chem Acta. 2002;323(1–2):121–128.
  • Hellerstein S, Berenbom M, Erwin P, Wilson N, DiMaggio S. The ratio of urinary cystatin C to urinary creatinine for detecting decreased GFR. Pediatr Nephrol. 2004;19(5):521–525.
  • Tian S, Kusano E, Ohara T, . Cystatin C measurement and its practical use in patients with various renal disease. Clin Nephrol. 1997;48(2):104–108.
  • Tkaczyk M, Nowicki M, Lukamowicz J. Increased cystatin C concentration in urine of nephrotic children. Pediatr Nephrol. 2004;19(11):1278–1280.
  • Uslu S, Efe B, Alatas O, . Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients. J Nephrol. 2005;18(5):559–567.
  • Thielemans N, Lauwerys R, Bernard A. Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies. Nephron. 1994;66(4): 453–458.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.